Maximal benefit of minimal residual disease monitoring in pediatric acute myeloid leukemia
Haematologica
.
2024 Mar 1;109(3):701-703.
doi: 10.3324/haematol.2023.283765.
Authors
Henrik Hasle
1
,
Kristian Løvvik Juul-Dam
2
Affiliations
1
Department of pediatrics and adolescent medicine, Aarhus University Hospital, Aarhus. hasle@dadlnet.dk.
2
Department of pediatrics and adolescent medicine, Aarhus University Hospital, Aarhus.
PMID:
37675508
PMCID:
PMC10905066
DOI:
10.3324/haematol.2023.283765
No abstract available
MeSH terms
Child
Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / therapy
Neoplasm, Residual / diagnosis